Omada Health Statistics
Total Valuation
Omada Health has a market cap or net worth of $705.34 million. The enterprise value is $516.02 million.
Important Dates
The next estimated earnings date is Sunday, May 17, 2026, after market close.
| Earnings Date | May 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Omada Health has 58.93 million shares outstanding. The number of shares has increased by 374.54% in one year.
| Current Share Class | 58.93M |
| Shares Outstanding | 58.93M |
| Shares Change (YoY) | +374.54% |
| Shares Change (QoQ) | +10.88% |
| Owned by Insiders (%) | 2.98% |
| Owned by Institutions (%) | 64.80% |
| Float | 43.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 62.87 |
| PS Ratio | 2.84 |
| Forward PS | 2.28 |
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.45 |
| P/FCF Ratio | 43.61 |
| P/OCF Ratio | 40.45 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 30.48 |
Financial Position
The company has a current ratio of 3.60
| Current Ratio | 3.60 |
| Quick Ratio | 3.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.72 |
Financial Efficiency
Return on equity (ROE) is -8.68% and return on invested capital (ROIC) is -4.61%.
| Return on Equity (ROE) | -8.68% |
| Return on Assets (ROA) | -3.28% |
| Return on Invested Capital (ROIC) | -4.61% |
| Return on Capital Employed (ROCE) | -5.21% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $284,072 |
| Profits Per Employee | -$13,950 |
| Employee Count | 916 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 22.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.93 |
| 200-Day Moving Average | 18.07 |
| Relative Strength Index (RSI) | 36.91 |
| Average Volume (20 Days) | 1,131,766 |
Short Selling Information
The latest short interest is 2.84 million, so 4.83% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short Previous Month | 3.60M |
| Short % of Shares Out | 4.83% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Omada Health had revenue of $260.21 million and -$12.78 million in losses. Loss per share was -$0.35.
| Revenue | 260.21M |
| Gross Profit | 170.94M |
| Operating Income | -11.97M |
| Pretax Income | -12.78M |
| Net Income | -12.78M |
| EBITDA | -6.48M |
| EBIT | -11.97M |
| Loss Per Share | -$0.35 |
Full Income StatementBalance Sheet
The company has $222.32 million in cash and n/a in debt, with a net cash position of $222.32 million or $3.77 per share.
| Cash & Cash Equivalents | 222.32M |
| Total Debt | n/a |
| Net Cash | 222.32M |
| Net Cash Per Share | $3.77 |
| Equity (Book Value) | 229.68M |
| Book Value Per Share | 3.93 |
| Working Capital | 197.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.25 million and capital expenditures -$1.32 million, giving a free cash flow of $16.93 million.
| Operating Cash Flow | 18.25M |
| Capital Expenditures | -1.32M |
| Depreciation & Amortization | 5.49M |
| Net Borrowing | -30.96M |
| Free Cash Flow | 16.93M |
| FCF Per Share | $0.29 |
Full Cash Flow StatementMargins
Gross margin is 65.69%, with operating and profit margins of -4.60% and -4.91%.
| Gross Margin | 65.69% |
| Operating Margin | -4.60% |
| Pretax Margin | -4.91% |
| Profit Margin | -4.91% |
| EBITDA Margin | -2.49% |
| EBIT Margin | -4.60% |
| FCF Margin | 6.51% |
Dividends & Yields
Omada Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -374.54% |
| Shareholder Yield | -374.54% |
| Earnings Yield | -1.73% |
| FCF Yield | 2.29% |
Analyst Forecast
The average price target for Omada Health is $22.70, which is 89.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.70 |
| Price Target Difference | 89.64% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omada Health has an Altman Z-Score of 8.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.53 |
| Piotroski F-Score | 5 |
